Edition:
United States

Editas Medicine Inc (EDIT.OQ)

EDIT.OQ on NASDAQ Stock Exchange Global Select Market

36.25USD
20 Jul 2018
Change (% chg)

$0.12 (+0.33%)
Prev Close
$36.13
Open
$36.00
Day's High
$36.69
Day's Low
$35.79
Volume
153,697
Avg. Vol
324,853
52-wk High
$45.02
52-wk Low
$15.28

Select another date:

Fri, May 18 2018

BRIEF-Editas Medicine Reports Data Demonstrating Subretinal Injection Of Edit-101 Well-Tolerated In Non-Human Primates

* EDITAS MEDICINE REPORTS DATA DEMONSTRATING SUBRETINAL INJECTION OF EDIT-101 WELL-TOLERATED IN NON-HUMAN PRIMATES

BRIEF-Editas Medicine Reports Q1 Loss Per Share Of $0.67

* EDITAS MEDICINE ANNOUNCES FIRST QUARTER 2018 RESULTS AND UPDATE

BRIEF-Editas Medicine Names James Mullen As Chairman Of Board

* EDITAS MEDICINE NAMES JAMES C. MULLEN AS CHAIRMAN OF THE BOARD OF DIRECTORS

BRIEF-Editas Medicine Inc Files For Mixed Shelf Of Up To $150 Million – SEC Filing‍​

* EDITAS MEDICINE INC FILES FOR MIXED SHELF OF UP TO $150 MILLION – SEC FILING‍​ Source text (http://bit.ly/2GlXQp9) Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-Editas Medicine Q4 Loss Per Share $0.84

* EDITAS MEDICINE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 RESULTS AND UPDATE

BRIEF-Adverum Biotechnologies Extends Collaboration Agreement With Editas Medicine

* ANNOUNCES EXTENSION OF ITS COLLABORATION AGREEMENT WITH EDITAS MEDICINE INC

Select another date: